You just read:

Cancer Care Ontario Adds PERJETA®-HERCEPTIN® Combo Pack for Treatment of HER2-Positive Metastatic Breast Cancer to the Provincial Formulary

News provided by

Roche Canada

Dec 11, 2013, 08:00 ET